455 related articles for article (PubMed ID: 25274401)
1. Therapeutic strategies for neuroendocrine liver metastases.
Frilling A; Clift AK
Cancer; 2015 Apr; 121(8):1172-86. PubMed ID: 25274401
[TBL] [Abstract][Full Text] [Related]
2. Treatment options for unresectable neuroendocrine liver metastases.
John BJ; Davidson BR
Expert Rev Gastroenterol Hepatol; 2012 Jun; 6(3):357-69. PubMed ID: 22646257
[TBL] [Abstract][Full Text] [Related]
3. Management of patients with hepatic metastases from neuroendocrine tumors.
Clift AK; Frilling A
Ann Saudi Med; 2014; 34(4):279-90. PubMed ID: 25811199
[TBL] [Abstract][Full Text] [Related]
4. [Liver metastases from neuroendocrine tumours of the gastroenteropancreatic system--therapeutic strategies].
Auernhammer CJ; Jauch KW; Hoffmann JN
Zentralbl Chir; 2009 Sep; 134(5):410-7. PubMed ID: 19757340
[TBL] [Abstract][Full Text] [Related]
5. The Landmark Series: Neuroendocrine Tumor Liver Metastases.
Gangi A; Howe JR
Ann Surg Oncol; 2020 Sep; 27(9):3270-3280. PubMed ID: 32632880
[TBL] [Abstract][Full Text] [Related]
6. Improved outcome with cytoreduction versus embolization for symptomatic hepatic metastases of carcinoid and neuroendocrine tumors.
Osborne DA; Zervos EE; Strosberg J; Boe BA; Malafa M; Rosemurgy AS; Yeatman TJ; Carey L; Duhaine L; Kvols LK
Ann Surg Oncol; 2006 Apr; 13(4):572-81. PubMed ID: 16511671
[TBL] [Abstract][Full Text] [Related]
7. Radioembolization in the treatment of neuroendocrine tumors of the pancreas.
John PK; Saif MW
JOP; 2014 Jul; 15(4):332-4. PubMed ID: 25076336
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcome after chemoembolization and embolization of hepatic metastatic lesions from neuroendocrine tumors.
Ho AS; Picus J; Darcy MD; Tan B; Gould JE; Pilgram TK; Brown DB
AJR Am J Roentgenol; 2007 May; 188(5):1201-7. PubMed ID: 17449759
[TBL] [Abstract][Full Text] [Related]
9. Treatment of neuroendocrine cancer metastatic to the liver: the role of ablative techniques.
Atwell TD; Charboneau JW; Que FG; Rubin J; Lewis BD; Nagorney DM; Callstrom MR; Farrell MA; Pitot HC; Hobday TJ
Cardiovasc Intervent Radiol; 2005; 28(4):409-21. PubMed ID: 16041556
[TBL] [Abstract][Full Text] [Related]
10. Management of gastroentero-pancreatic neuroendocrine tumors (GEP-NETs).
Desai KK; Khan MS; Toumpanakis C; Caplin ME
Minerva Gastroenterol Dietol; 2009 Dec; 55(4):425-43. PubMed ID: 19942827
[TBL] [Abstract][Full Text] [Related]
11. Management of advanced neuroendocrine tumors with hepatic metastasis.
Khasraw M; Gill A; Harrington T; Pavlakis N; Modlin I
J Clin Gastroenterol; 2009 Oct; 43(9):838-47. PubMed ID: 19654558
[TBL] [Abstract][Full Text] [Related]
12. New treatment strategies in advanced neuroendocrine tumours.
Walter T; Brixi-Benmansour H; Lombard-Bohas C; Cadiot G
Dig Liver Dis; 2012 Feb; 44(2):95-105. PubMed ID: 21983252
[TBL] [Abstract][Full Text] [Related]
13. Systemic treatment of neuroendocrine tumors with hepatic metastases.
Demirkan BH; Eriksson B
Turk J Gastroenterol; 2012; 23(5):427-37. PubMed ID: 23161287
[TBL] [Abstract][Full Text] [Related]
14. Treatment of hepatic metastases of neuroendocrine malignancies: a 10-year experience.
Dejong CH; Parks RW; Currie E; Piris J; Redhead DN; Garden OJ
J R Coll Surg Edinb; 2002 Apr; 47(2):495-9. PubMed ID: 12018694
[TBL] [Abstract][Full Text] [Related]
15. Neuroendocrine liver metastases.
Reddy SK; Clary BM
Surg Clin North Am; 2010 Aug; 90(4):853-61. PubMed ID: 20637952
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic strategies for advanced neuroendocrine carcinomas of jejunum/ileum and pancreatic origin.
Auernhammer CJ; Göke B
Gut; 2011 Jul; 60(7):1009-21. PubMed ID: 21378384
[TBL] [Abstract][Full Text] [Related]
17. Metastatic neuroendocrine hepatic tumors: resection improves survival.
Musunuru S; Chen H; Rajpal S; Stephani N; McDermott JC; Holen K; Rikkers LF; Weber SM
Arch Surg; 2006 Oct; 141(10):1000-4; discussion 1005. PubMed ID: 17043278
[TBL] [Abstract][Full Text] [Related]
18. Transarterial liver-directed therapies of neuroendocrine hepatic metastases.
Nazario J; Gupta S
Semin Oncol; 2010 Apr; 37(2):118-26. PubMed ID: 20494704
[TBL] [Abstract][Full Text] [Related]
19. Multimodal management of neuroendocrine liver metastases.
Frilling A; Sotiropoulos GC; Li J; Kornasiewicz O; Plöckinger U
HPB (Oxford); 2010 Aug; 12(6):361-79. PubMed ID: 20662787
[TBL] [Abstract][Full Text] [Related]
20. Management of pancreatic neuroendocrine tumors.
Dickson PV; Behrman SW
Surg Clin North Am; 2013 Jun; 93(3):675-91. PubMed ID: 23632152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
